Comparing the current results to its competitors, West Pharmaceutical Services Inc reported Revenue increase in the 2 quarter 2026 by 13.89 % year on year. The sales growth was above West Pharmaceutical Services Inc 's competitors' average revenue growth of 10.18 %, achieved in the same quarter.
West Pharmaceutical Services Inc 's Comment on Competition and Industry Peers
We compete with several companies across our Proprietary Products product lines.
Due to the special nature of our pharmaceutical packaging components and our long-standing
participation in the market, competition for these components is based primarily
on product design and performance, although total cost is becoming increasingly
important as pharmaceutical companies continue with aggressive cost-control programs
across their operations.
In addition, there is a small number of competitors supplying medical devices
and medical device components. We compete in this market on the basis of our
reputation for quality and reliability in engineering and project management,
as well as our knowledge of, and experience in, compliance with regulatory requirements.
We also have specialized knowledge of container closure components, which is
integral to developing delivery systems. With our range of proprietary technologies,
we compete with new and established companies in the area of drug delivery devices,
including suppliers of prefillable syringes, auto-injectors, safety needles
and other proprietary systems.
We differentiate ourselves from our competition by being an integrated drug
containment and delivery systems global supplier that can provide pre-approval
primary packaging support and engineering development, analytical services,
regulatory expertise and after-sale technical support. Customers also appreciate
the global scope of our manufacturing capability and our ability to produce
many products at multiple sites.
Our Contract-Manufactured Products business operates in very competitive markets
for its products. The competition varies from smaller regional companies to
large global molders. Given the cost pressures they face, many of our customers
look off-shore to reduce cost. We differentiate ourselves by leveraging our
global capability and by employing new technologies such as high-speed automated
assembly, insert-molding, multi-shot molding and expertise with multiple-piece
closure systems.
Publicly Traded Peers of West Pharmaceutical Services Inc
Alcon inc Share Performance
-9.15%
This Year
Alcon inc
Profile
Alcon Inc's business model revolves around providing advanced eye care products and services, including pharmaceuticals, surgical equipment, and vision care solutions.
Danaher Corporation operates a diversified business model centered on developing advanced technologies and solutions across multiple sectors, particularly life sciences, diagnostics, dental, and environmental. The company emphasizes continuous innovation and operational excellence, leveraging its proprietary technologies to drive growth and improve efficiency. By strategically acquiring and integrating complementary businesses, Danaher enhances its product offerings while expanding its global market presence.
National Vision Holdings Inc is a leading retailer of eyewear and optical products in the United States. The company operates a vertically integrated business model, which involves manufacturing, marketing, and distributing a wide range of eyewear products through its branded retail stores and third-party retail locations. National Vision Holdings Inc focuses on offering affordable and accessible vision care solutions to customers by leveraging its supply chain and retail network capabilities.
ICU Medical Inc's business model focuses on the development, manufacture, and sale of innovative medical devices and solutions for critical care settings.
Sources:
West Pharmaceutical Services Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on West Pharmaceutical Services Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.